-
COST-EFFECTIVENESS OF OBINUTUZUMAB FOR THE TREATMENT OF ACTIVE LUPUS NEPHRITIS IN THE UK
Aug 11, 2026, 17:16 PM -
COMPARATIVE EVALUATION OF GRAPH RETRIEVAL-AUGMENTED GENERATION (GRAPHRAG) AND CONVENTIONAL RAG FOR EVIDENCE SYNTHESIS
Aug 11, 2026, 17:16 PM -
UNDERSTANDING DIETS FROM THE ROOTS: OPPORTUNITIES AND LIMITATIONS IN THE INFODEMIOLOGICAL ANALYSIS OF INFORMATION-SEEKING BEHAVIOR REGARDING MACRONUTRIENTS IN THE HUNGARIAN POPULATION
Aug 11, 2026, 17:16 PM -
ECONOMIC BURDEN BEFORE AND AFTER SJOGREN'S DISEASE DIAGNOSIS IN THE US: A RETROSPECTIVE CLAIMS-BASED ANALYSIS
Aug 11, 2026, 17:16 PM -
PHARMACEUTICAL PAYBACK BURDEN AND HEALTH TECHNOLOGY ASSESSMENT (HTA) MATURITY ACROSS EU MEMBER STATES: A SCOPING REVIEW
Aug 11, 2026, 17:16 PM -
IMPACT OF THE NEW UK EQ-5D-5L VALUE SET ON HEALTH STATE UTILITY VALUES: A MULTI-COUNTRY COMPARISON ACROSS DISEASE GROUPS
Aug 11, 2026, 17:16 PM -
THE IMPACT OF CAREGIVING FOR PEOPLE WITH AUTOIMMUNE NEUROMUSCULAR DISORDERS (ANMD): A LITERATURE REVIEW
Aug 11, 2026, 17:16 PM -
HUMAN-IN-THE-LOOP AI-ASSISTED FULL TEXT REVIEW FOR SAFETY EVIDENCE IDENTIFICATION
Aug 11, 2026, 17:16 PM -
BENEFIT AND BURDEN OF MULTI-CANCER DETECTION - A BAYESIAN, SIMULATION-BASED ANALYSIS
Aug 11, 2026, 17:16 PM -
GEOGRAPHICAL ANALYSIS OF INJECTION NUMBER AND BURDEN IN DENMARK (GAIN-DK)
Aug 11, 2026, 17:16 PM -
EVIDENCE-CENTERED DECISION INTELLIGENCE FOR HTA: A CLOUD-BASED MILP-MCDA OPTIMIZATION AND FRAGILITY FRAMEWORK FOR HIGH-VALUE THERAPIES
Aug 11, 2026, 17:16 PM -
WHEN GUIDANCE MEETS REALITY: LESSONS FROM RECENT HTA SUBMISSIONS IN REPORTING EFFECT MODIFIERS
Aug 11, 2026, 17:16 PM -
IMPACT OF MOST FAVORED NATION (MFN) POLICY CHANGES: SURVEY OF PAYER INSIGHTS
Aug 11, 2026, 17:16 PM -
A METHODOLOGICAL FRAMEWORK FOR IDENTIFYING PROGNOSTIC FACTORS AND TREATMENT EFFECT MODIFIERS FOR EU JOINT CLINICAL ASSESSMENT AND GLOBAL HTA
Aug 11, 2026, 17:16 PM -
EARLY NETWORK META-ANALYSIS IN GENERALIZED MYASTHENIA GRAVIS USING TIME-COURSE ADJUSTMENT THROUGH MODEL-BASED NETWORK META-ANALYSIS
Aug 11, 2026, 17:16 PM -
PUBLIC HEALTH IMPACT OF EXPANDING PREP UPTAKE AMONG SWISS MSM: A MICROSIMULATION MODEL COMPARING ORAL AND TWICE-YEARLY INJECTABLE REGIMENS
Aug 11, 2026, 17:16 PM -
FROM EIGHT PICOS TO ONE: SCOPE COLLAPSE IN THE FIRST ORPHAN ONCOLOGY JOINT CLINICAL ASSESSMENT
Aug 11, 2026, 17:16 PM -
THERAPEUTIC INNOVATION, COST PER RESPONDER, AND PHARMACEUTICAL EXPENDITURE GROWTH IN CROHN'S DISEASE AND IMMUNE-MEDIATED DISEASES IN GREECE
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF TAPERING BIOLOGICS IN RHEUMATOID ARTHRITIS PATIENTS: A REAL-WORLD, MULTICENTER COHORT STUDY
Aug 11, 2026, 17:16 PM -
ASSESSING EVIDENCE TRANSFERABILITY BETWEEN EU JOINT CLINICAL ASSESSMENT AND NATIONAL HTA IN RARE ONCOLOGY: A CROSS-MARKET FRAMEWORK
Aug 11, 2026, 17:16 PM
